 A baseline blood sample will be drawn to assess coagulation using thromboelastography TEG. TEG is a point-of-care device which measures the viscoelastic properties of clot formation. This device can provide rapid and detailed information about coagulation changes. TEG will be used to assess coagulation changes after commencing treatment with enoxaparin see later. 